NCT00379600View on ClinicalTrials.gov

The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

rosiglitazone XR

Trial Locations (5)

LT-45130

GSK Investigational Site, Kaunas

LT-08661

GSK Investigational Site, Vilnius

G12 0YN

GSK Investigational Site, Glasgow

G21 3UW

GSK Investigational Site, Glasgow

G31 2ER

GSK Investigational Site, Glasgow

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY